These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 34492233)

  • 1. Nucleic acid delivery for therapeutic applications.
    Gupta A; Andresen JL; Manan RS; Langer R
    Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.
    Cha W; Fan R; Miao Y; Zhou Y; Qin C; Shan X; Wan X; Li J
    Molecules; 2017 May; 22(5):. PubMed ID: 28492505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.
    Tarach P; Janaszewska A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic Acid Therapies for Cystic Fibrosis.
    Sasaki S; Guo S
    Nucleic Acid Ther; 2018 Feb; 28(1):1-9. PubMed ID: 29160746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.
    Dowdy SF; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):107-108. PubMed ID: 29782220
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
    Ita K
    Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
    Johannes L; Lucchino M
    Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of nucleic acids and opportunities for cancer treatment.
    Brannon-Peppas L; Ghosn B; Roy K; Cornetta K
    Pharm Res; 2007 Apr; 24(4):618-27. PubMed ID: 17372693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic Acid Therapeutics in Huntington's Disease.
    Singh K; Roy I
    Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
    Vaughan HJ; Green JJ; Tzeng SY
    Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
    Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
    Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological applications of xeno nucleic acids.
    Morihiro K; Kasahara Y; Obika S
    Mol Biosyst; 2017 Jan; 13(2):235-245. PubMed ID: 27827481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
    Ashizawa AT; Cortes J
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.
    Fattal E; Bochot A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1203-23. PubMed ID: 17097190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative developments and emerging technologies in RNA therapeutics.
    Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
    RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.